Antiretroviral combination therapies and AIDS-defining cancers

被引：0
|
作者：
Serraino, D [1 ]
Pezzotti, P
Boros, S
Rezza, G
机构：
[1] Ist Ricovers & Cura Carottere Sci Lazzaro Spallan, Ctr Riferimento AIDS, Rome, Italy
[2] Ist Ricovers & Cura Carottere Sci Lazzaro Spallan, Serv Epidemiol Malattie Infett, Rome, Italy
[3] Ist Super Sanita, Reparto AIDS & Malattie Sussualmente Trasmesse, I-00161 Rome, Italy
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 24卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：84 / 86
页数：3
相关论文
共 50 条
  • [41] Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral therapy (vol 174, pg 768, 2021)
    Chammartin, F.
    Lodi, S.
    Logan, R.
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (08) : 1195 - 1195
  • [42] Paradoxical Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Treated With Combination Antiretroviral Therapy After AIDS-Defining Opportunistic Infection
    Achenbach, Chad J.
    Harrington, Robert D.
    Dhanireddy, Shireesha
    Crane, Heidi M.
    Casper, Corey
    Kitahata, Mari M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (03) : 424 - 433
  • [43] The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post-Combination Antiretroviral Therapy Era
    Mocroft, A.
    Furrer, H. J.
    Miro, J. M.
    Reiss, P.
    Mussini, C.
    Kirk, O.
    Abgrall, S.
    Ayayi, S.
    Bartmeyer, B.
    Braun, D.
    Castagna, A.
    Monforte, A. d'Arminio
    Gazzard, B.
    Gutierrez, F.
    Hurtado, I.
    Jansen, K.
    Meyer, L.
    Munoz, P.
    Obel, N.
    Soler-Palacin, P.
    Papadopoulos, A.
    Raffi, F.
    Ramos, J. T.
    Rockstroh, J. K.
    Salmon, D.
    Torti, C.
    Warszawski, J.
    de Wit, S.
    Zangerle, R.
    Fabre-Colin, C.
    Kjaer, J.
    Chene, G.
    Grarup, J.
    Lundgren, J. D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) : 1038 - 1047
  • [44] Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy
    Grabar, S.
    Lanoy, E.
    Allavena, C.
    Mary-Krause, M.
    Bentata, M.
    Fischer, P.
    Mahamat, A.
    Rabaud, C.
    Costagliola, D.
    [J]. HIV MEDICINE, 2008, 9 (04) : 246 - 256
  • [45] Kaposi sarcoma: No longer an AIDS-defining illness?
    Daly, Marie-Louise
    Fogo, Abigail
    McDonald, Candice
    Morris-Jones, Rachael
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB134 - AB134
  • [46] Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters
    Cain, LE
    Cole, SR
    Chmiel, JS
    Margolick, JB
    Rinaldo, CR
    Detels, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (04) : 310 - 315
  • [47] Survival of AIDS patients according to type of AIDS-defining event
    Mocroft, AJ
    Lundgren, JD
    Monforte, AD
    Ledergerber, B
    Barton, SE
    Vella, S
    Katlama, C
    Gerstoft, J
    Pedersen, C
    Phillips, AN
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (02) : 400 - 407
  • [48] THE ROLE OF INITIAL AIDS-DEFINING ILLNESS IN SURVIVAL FOLLOWING AIDS
    LUO, KH
    LAW, M
    KALDOR, JM
    MCDONALD, AM
    COOPER, DA
    [J]. AIDS, 1995, 9 (01) : 57 - 63
  • [49] TOXIC SHOCK SYNDROME AS THE AIDS-DEFINING DIAGNOSIS
    FINKELSTEIN, S
    HYLAND, RH
    [J]. CHEST, 1993, 104 (03) : 950 - 951
  • [50] The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic
    Ives, NJ
    Gazzard, BG
    Easterbrook, PJ
    [J]. JOURNAL OF INFECTION, 2001, 42 (02) : 134 - 139
12345